Although tumor CD274 (PD‐L1) overexpression does not appear to have a prognostic role in colorectal carcinoma,2, 6 our previous study indicates that tumor CD274 overexpression may serve as a predictive biomarker for tumor resistance to aspirin use after colorectal cancer diagnosis.39 This evidence concerns the gene CD274 and colorectal cancer.